Aurinia Pharmaceuticals Ownership | Who Owns Aurinia Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Aurinia Pharmaceuticals Ownership Summary


Aurinia Pharmaceuticals is owned by 40.12% institutional investors, 7.16% insiders, and 52.72% retail investors. Armistice capital is the largest institutional shareholder, holding 7.73% of AUPH shares. iShares Russell 2000 ETF is the top mutual fund, with 2.54% of its assets in Aurinia Pharmaceuticals shares.

AUPH Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAurinia Pharmaceuticals40.12%7.16%52.72%
SectorHealthcare Stocks 88.01%8.90%3.09%
IndustryBiotech Stocks 109.70%8.77%-18.47%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Armistice capital11.14M7.73%$63.59M
Blackrock9.27M6.44%$52.94M
Blackrock funding, inc. /de8.95M6.26%$80.39M
Nea management company3.97M2.76%$22.67M
State street2.88M2.00%$16.45M
Tang capital management2.78M1.93%$15.87M
Geode capital management1.76M1.23%$15.84M
Goldman sachs group1.75M1.22%$15.73M
Vanguard group1.73M1.21%$15.53M
Nuveen asset management1.49M1.04%$13.40M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Nea management company3.97M1.71%$22.67M
Tang capital management2.78M1.62%$15.87M
Armistice capital11.14M0.80%$63.59M
Ironwood investment management94.31K0.42%$846.90K
Virtus investment advisers82.83K0.40%$472.95K
Rock springs capital management lp1.18M0.20%$6.74M
Virtus etf advisers61.56K0.17%$351.51K
Virtus fund advisers6.79K0.15%$38.76K
Highmark wealth management21.70K0.11%$194.83K
Sunbelt securities160.22K0.09%$914.88K

Top Buyers

HolderShares% AssetsChange
Arrowstreet capital, limited partnership1.08M0.01%1.08M
Tang capital management2.78M1.62%729.50K
Blackrock9.27M0.00%609.18K
Jpmorgan chase927.30K0.00%424.48K
Renaissance700.90K0.01%214.20K

Top Sellers

HolderShares% AssetsChange
Armistice capital11.14M0.80%-1.12M
Schroder investment management group---997.22K
Goldman sachs group1.75M0.00%-655.85K
683 capital management---400.00K
Group one trading---377.32K

New Positions

HolderShares% AssetsChangeValue
Arrowstreet capital, limited partnership1.08M0.01%1.08M$9.66M
Qube research195.76K0.00%195.76K$1.76M
Pdt partners171.35K0.09%171.35K$978.40K
Norges bank114.05K0.00%114.05K$651.20K
Virtus investment advisers82.83K0.40%82.83K$472.95K

Sold Out

HolderChange
Vima-25.00
Nelson, van denburg & campbell wealth management group-26.00
Walleye trading-300.00
Spectrum wealth counsel-334.00
Lowe wealth advisors-531.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20241957.73%57,393,9453.76%402.69%83-2.35%43-
Jun 30, 2024180-8.63%55,314,7510.64%382.61%8513.33%42-32.26%
Mar 31, 2024197-6.19%54,961,1773.27%382.78%75-9.64%621.64%
Dec 31, 2023210-2.78%53,221,0035.95%373.00%83-10.75%6122.00%
Sep 30, 2023216-1.37%50,234,1310.83%352.88%93-2.11%50-9.09%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Russell 2000 ETF3.63M2.54%-27.60K
Fidelity Small Cap Index1.37M0.96%-3.10K
Nuveen Quant Small Cap Equity R61.10M0.77%-
International Biotechnology Ord997.22K0.70%-
iShares Russell 2000 Growth ETF881.08K0.62%-4.13K
State St Russell Sm/Mid Cp® Indx NL Cl C827.90K0.58%-72.30K
iShares Biotechnology ETF815.09K0.57%-1.73K
Vanguard Russell 2000 ETF636.38K0.44%6.36K
State St Russell Sm Cap® Indx SL Cl I464.95K0.32%-
Vanguard Health Care ETF395.46K0.28%-4.09K

Recent Insider Transactions


DateNameRoleActivityValue
Dec 05, 2024TANG KEVIN-Buy$2.67M
Dec 09, 2024TANG KEVIN-Buy$4.54M
Dec 06, 2024TANG KEVIN-Buy$3.60M
Nov 11, 2024Bailey Jeffrey Allen-Sell$38.42K
Nov 11, 2024Smith Karen L.-Sell$44.18K

Insider Transactions Trends


DateBuySell
2024 Q432
2024 Q3-1
2024 Q2-5
2024 Q1-8
2023 Q3--

AUPH Ownership FAQ


Who Owns Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals shareholders are primarily institutional investors at 40.12%, followed by 7.16% insiders and 52.72% retail investors. The average institutional ownership in Aurinia Pharmaceuticals's industry, Biotech Stocks , is 109.70%, which Aurinia Pharmaceuticals falls below.

Who owns the most shares of Aurinia Pharmaceuticals?

Aurinia Pharmaceuticals’s largest shareholders are Armistice capital (11.14M shares, 7.73%), Blackrock (9.27M shares, 6.44%), and Blackrock funding, inc. /de (8.95M shares, 6.26%). Together, they hold 20.43% of Aurinia Pharmaceuticals’s total shares outstanding.

Does Blackrock own Aurinia Pharmaceuticals?

Yes, BlackRock owns 6.44% of Aurinia Pharmaceuticals, totaling 9.27M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 52.94M$. In the last quarter, BlackRock increased its holdings by 609.18K shares, a 7.03% change.

Who is Aurinia Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Nea management company is Aurinia Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 1.71% of its assets in 3.97M Aurinia Pharmaceuticals shares, valued at 22.67M$.

Who is the top mutual fund holder of Aurinia Pharmaceuticals shares?

iShares Russell 2000 ETF is the top mutual fund holder of Aurinia Pharmaceuticals shares, with 2.54% of its total shares outstanding invested in 3.63M Aurinia Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools